BEAM · Categories · Form 4

BEAM - SEC Form 4 insider transactions

Beam Therapeutics Inc. (BEAM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BEAM

• 3d
  SEC Form 4 filed by Director Maraganore John

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 3d
  SEC Form 4 filed by Director Walsh Kathleen E

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 3d
  SEC Form 4 filed by Director Shaw Christi

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 3d
  SEC Form 4 filed by Director Guindo Chirfi

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 3d
  SEC Form 4 filed by Director Cooper Graham K

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 3d
  SEC Form 4 filed by Director Fishman Mark

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 63d
  SEC Form 4 filed by Evans John M.

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 63d
  SEC Form 4 filed by Simon Amy

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 63d
  SEC Form 4 filed by Bellon Christine

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 63d
  SEC Form 4 filed by Cavanagh Bethany J

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 63d
  SEC Form 4 filed by Ciaramella Giuseppe

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 67d
  SEC Form 4 filed by Bellon Christine

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 67d
  SEC Form 4 filed by Cavanagh Bethany J

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 67d
  SEC Form 4 filed by Simon Amy

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 67d
  SEC Form 4 filed by Emany Sravan Kumar

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 67d
  SEC Form 4 filed by Ciaramella Giuseppe

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 68d
  SEC Form 4 filed by Evans John M.

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 102d
  President Ciaramella Giuseppe exercised 35,000 shares at a strike of $17.00 and sold $1,120,042 worth of shares (35,000 units at $32.00) (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 126d
  SEC Form 4 filed by Chief Legal Officer Bellon Christine

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 126d
  SEC Form 4 filed by President Ciaramella Giuseppe

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 126d
  SEC Form 4 filed by Chief Financial Officer Emany Sravan Kumar

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 126d
  SEC Form 4 filed by SVP, Finance and Treasurer Cavanagh Bethany J

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 126d
  SEC Form 4 filed by Chief Medical Officer Simon Amy

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 126d
  CEO Evans John M. exercised 50,000 shares at a strike of $0.67 and sold $1,443,528 worth of shares (50,000 units at $28.87) (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 133d
  SVP, Finance and Treasurer Cavanagh Bethany J sold $216,933 worth of shares (6,198 units at $35.00), decreasing direct ownership by 15% to 34,813 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 133d
  Chief Legal Officer Bellon Christine sold $46,614 worth of shares (1,371 units at $34.00), decreasing direct ownership by 1% to 95,667 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 138d
  SVP, Finance and Treasurer Cavanagh Bethany J sold $91,384 worth of shares (3,034 units at $30.12), decreasing direct ownership by 7% to 41,011 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 139d
  Chief Legal Officer Bellon Christine sold $644,832 worth of shares (18,629 units at $34.61), decreasing direct ownership by 16% to 97,038 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 154d
  Chief Financial Officer Emany Sravan Kumar sold $170,567 worth of shares (6,294 units at $27.10), decreasing direct ownership by 8% to 73,706 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 154d
  Chief Legal Officer Bellon Christine sold $33,983 worth of shares (1,254 units at $27.10), decreasing direct ownership by 1% to 115,667 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 154d
  Chief Medical Officer Simon Amy was granted 12,500 shares, increasing direct ownership by 19% to 77,364 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 223d
  See Remark 1 Fmr Llc sold $12,246 worth of shares (459 units at $26.68) (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 243d
  See Remark 1 Fmr Llc gifted 1,232,434 shares (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 248d
  SVP, Finance and Treasurer Cavanagh Bethany J sold $11,456 worth of shares (467 units at $24.53), decreasing direct ownership by 1% to 44,045 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 248d
  Chief Legal Officer Bellon Christine sold $9,150 worth of shares (373 units at $24.53), decreasing direct ownership by 0.32% to 116,921 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 248d
  CEO Evans John M. exercised 50,000 shares at a strike of $0.67 and sold $1,228,322 worth of shares (50,000 units at $24.57) (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 312d
  See Remark 1 Fmr Llc sold $991,667 worth of shares (48,374 units at $20.50) (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 340d
  Chief Medical Officer Simon Amy sold $23,962 worth of shares (1,250 units at $19.17), decreasing direct ownership by 2% to 64,864 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 367d
  SEC Form 4 filed by Director Walsh Kathleen E

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 367d
  SEC Form 4 filed by Director Shaw Christi

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 367d
  SEC Form 4 filed by Director Fishman Mark

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 367d
  SEC Form 4 filed by Director Ho Carole

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 367d
  SEC Form 4 filed by Director Maraganore John

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 367d
  SEC Form 4 filed by Director Guindo Chirfi

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 367d
  SEC Form 4 filed by Director Cooper Graham K

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 431d
  Chief Legal Officer Bellon Christine sold $104,122 worth of shares (5,674 units at $18.35), decreasing direct ownership by 5% to 117,294 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 431d
  President Ciaramella Giuseppe sold $136,418 worth of shares (7,434 units at $18.35), decreasing direct ownership by 4% to 190,216 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 431d
  CEO Evans John M. sold $562,684 worth of shares (30,663 units at $18.35), decreasing direct ownership by 3% to 986,249 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 431d
  SVP, Finance and Treasurer Cavanagh Bethany J sold $55,330 worth of shares (3,015 units at $18.35), decreasing direct ownership by 6% to 44,512 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 431d
  Chief Medical Officer Simon Amy sold $547,835 worth of shares (30,563 units at $17.92), decreasing direct ownership by 32% to 65,742 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 432d
  Chief Legal Officer Bellon Christine was granted 20,000 shares, increasing direct ownership by 19% to 122,968 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 432d
  Chief Medical Officer Simon Amy was granted 27,500 shares, increasing direct ownership by 40% to 96,305 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 432d
  President Ciaramella Giuseppe was granted 35,000 shares, increasing direct ownership by 22% to 197,650 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 432d
  SVP, Finance and Treasurer Cavanagh Bethany J was granted 10,000 shares, increasing direct ownership by 27% to 47,527 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 432d
  CEO Evans John M. was granted 77,500 shares, increasing direct ownership by 8% to 1,016,159 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 432d
  Amendment: CEO Evans John M. exercised 30,000 shares at a strike of $0.67, increasing direct ownership by 3% to 968,659 units (SEC Form 4)

  4/A - Beam Therapeutics Inc. (0001745999) (Issuer)
• 473d
  SVP, Finance and Treasurer Cavanagh Bethany J sold $220,045 worth of shares (6,287 units at $35.00), decreasing direct ownership by 14% to 37,527 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 474d
  Chief Legal Officer Bellon Christine exercised 10,000 shares at a strike of $7.22 and sold $340,000 worth of shares (10,000 units at $34.00) (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 490d
  CEO Evans John M. sold $802,484 worth of shares (30,000 units at $26.75), decreasing direct ownership by 3% to 908,659 units (SEC Form 4)

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)
• 490d
  SEC Form 4 filed by Chief Medical Officer Simon Amy

  4 - Beam Therapeutics Inc. (0001745999) (Issuer)

Other BEAM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends